- Home
- HOLX vs TEVA Comparison
HOLX vs TEVA Comparison
Compare HOLX & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLX
- TEVA
- Stock Information
- Founded
- HOLX 1985
- TEVA 1901
- Country
- HOLX United States
- TEVA Israel
- Employees
- HOLX N/A
- TEVA N/A
- Industry
- HOLX Medical Electronics
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- HOLX Health Care
- TEVA Health Care
- Exchange
- HOLX Nasdaq
- TEVA Nasdaq
- Market Cap
- HOLX 14.8B
- TEVA 21.2B
- IPO Year
- HOLX 1990
- TEVA N/A
- Fundamental
- Price
- HOLX $68.27
- TEVA $18.46
- Analyst Decision
- HOLX Buy
- TEVA Strong Buy
- Analyst Count
- HOLX 13
- TEVA 7
- Target Price
- HOLX $77.00
- TEVA $24.71
- AVG Volume (30 Days)
- HOLX 1.7M
- TEVA 10.3M
- Earning Date
- HOLX 11-03-2025
- TEVA 11-05-2025
- Dividend Yield
- HOLX N/A
- TEVA N/A
- EPS Growth
- HOLX N/A
- TEVA N/A
- EPS
- HOLX 2.41
- TEVA N/A
- Revenue
- HOLX $4,038,900,000.00
- TEVA $16,628,000,000.00
- Revenue This Year
- HOLX $3.37
- TEVA $4.07
- Revenue Next Year
- HOLX $4.46
- TEVA $0.81
- P/E Ratio
- HOLX $28.25
- TEVA N/A
- Revenue Growth
- HOLX 1.29
- TEVA 2.08
- 52 Week Low
- HOLX $51.90
- TEVA $12.47
- 52 Week High
- HOLX $84.39
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- HOLX 57.95
- TEVA 50.61
- Support Level
- HOLX $63.19
- TEVA $18.46
- Resistance Level
- HOLX $70.90
- TEVA $19.98
- Average True Range (ATR)
- HOLX 1.72
- TEVA 0.50
- MACD
- HOLX 0.07
- TEVA -0.14
- Stochastic Oscillator
- HOLX 65.89
- TEVA 25.25
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.